Concept Architecture
Concept
Theoretically, Dynamic Transmission Model is a mathematical disease modelling framework that explicitly represents the transmission of infectious diseases through interactions between individuals or population groups over time. Unlike static models, it accounts for changes in infection risk resulting from interventions, behavioural change, immunity, demographic processes and pathogen dynamics. The approach is grounded in infectious disease epidemiology and dynamic systems theory and is used to estimate both direct and indirect effects, including herd immunity, within health economic evaluation.
Mathematically, Dynamic Transmission Models are most commonly represented as systems of ordinary differential equations (ODEs), difference equations or stochastic state-transition processes describing movement between epidemiological compartments. The mathematical framework estimates temporal changes in disease states, force of infection, transmission dynamics and intervention effects while allowing parameter uncertainty and population heterogeneity to be incorporated.
In practice, Dynamic Transmission Models are parameterised using epidemiological surveillance data, contact patterns, demographic information, natural history parameters and intervention characteristics. Parameters are estimated using statistical calibration, maximum likelihood estimation or Bayesian inference. The models are implemented to evaluate vaccination programmes, screening strategies, antimicrobial resistance interventions and other communicable disease policies where transmission between individuals influences both costs and health outcomes.
Purpose
Used to evaluate interventions affecting communicable disease transmission by estimating direct and indirect health effects, disease incidence, resource use, costs and cost-effectiveness over time within dynamically interacting populations.
Mathematical Formulae
Primary Formula
For a deterministic susceptible-infectious-recovered (SIR) transmission model:
dS/dt = ??SI/N
dI/dt = ?SI/N ? ?I
dR/dt = ?I
where:
- S = susceptible population
- I = infectious population
- R = recovered population
- N = S + I + R
- ? = transmission rate
- ? = recovery rate
Supporting Formulae
Force of infection:
? = ?I/N
Basic reproduction number:
R? = ?/?
Effective reproduction number:
R? = R?(S/N)
Related Mathematical Methods
- Ordinary differential equations
- Stochastic compartmental modelling
- Difference equation models
- Bayesian calibration
- Maximum likelihood estimation
- Markov chain Monte Carlo
- Sensitivity analysis
- Probabilistic sensitivity analysis
Example
A vaccination programme is evaluated in a population of 100,000 individuals.
Initial conditions:
- Susceptible = 99,000
- Infectious = 1,000
- Recovery rate (?) = 0.20 per week
- Transmission rate (?) = 0.40 per week
The basic reproduction number is:
R? = 0.40/0.20 = 2.0
Following vaccination, susceptibility declines, reducing the effective reproduction number below one. The model projects fewer infections, lower treatment costs and additional quality-adjusted life-years generated through both direct protection and herd immunity. These outcomes are incorporated into the economic evaluation.
Excel Implementation
| Function | Example Formula | Health Economics Application |
|---|---|---|
| SUM | =SUM(B2:B4) | Calculate total population across disease compartments. |
| EXP | =EXP(-B2*C2) | Calculate transition probabilities from continuous-time rates. |
| IF | =IF(Re<1,""Controlled"",""Growing"") | Assess epidemic control under intervention scenarios. |
| INDEX | =INDEX(ParameterTable,MATCH(""Beta"",Names,0),2) | Retrieve transmission parameters for scenario analyses. |
| Solver | Optimise calibration parameters | Estimate transmission parameters by minimising calibration error against observed incidence. |
VBA (Optional)
Automate repeated simulation of transmission dynamics across intervention scenarios and export projected epidemiological and economic outcomes.
Sources
- Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. 4th ed.
- Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation.
- NICE. Health Technology Evaluation Manual.
- ISPOR-SMDM Modeling Good Research Practices Task Force Reports.
- Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. Oxford University Press.
- Keeling MJ, Rohani P. Modeling Infectious Diseases in Humans and Animals. Princeton University Press.
Related Concepts (5)
Library
Publications
6
Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5 — Pitman, Fisman, Zaric, Postma, Kretzschmar, Edmunds & Brisson, Task Force Report 5 ed., 2012 (Value in Health / Medical Decision Making)
Best-practice guidance on dynamic transmission models for infectious disease, capturing indirect (herd) effects that static models cannot, and their use in cost-effectiveness analysis of vaccination and control programmes.
Journal ArticleView source →Applying Dynamic Simulation Modeling Methods in Health Care Delivery Research — The SIMULATE Checklist: Report of the ISPOR Simulation Modeling Emerging Good Practices Task Force — Marshall, Burgos-Liz, IJzerman, Osgood, Padula, Higashi, Wong, Pasupathy & Crown, Vol. 18, No. 1 ed., 2015 (Value in Health)
The first ISPOR dynamic-simulation good-practice report, introducing system dynamics, discrete event simulation and agent-based modelling for health care delivery problems and providing the SIMULATE checklist for their application.
Journal ArticleView source →Selecting a Dynamic Simulation Modeling Method for Health Care Delivery Research — Part 2: Report of the ISPOR Dynamic Simulation Modeling Emerging Good Practices Task Force — Marshall, Burgos-Liz, IJzerman, Crown, Padula, Wong, Pasupathy, Higashi & Osgood, Vol. 18, No. 2 ed., 2015 (Value in Health)
The second ISPOR dynamic-simulation report, giving decision guidance on choosing between system dynamics, discrete event simulation and agent-based modelling based on the structure and complexity of the health care delivery problem.
Journal ArticleView source →Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community — Ultsch, Damm, Beutels, Bilcke, et al., Vol. 34, No. 3 ed., 2016 (PharmacoEconomics)
A consensus framework on the immunisation-specific methodological issues in economic evaluation of vaccines — herd/indirect effects, discounting, dynamic transmission modelling — developed to support national vaccine HTA guidelines in Europe.
Journal ArticleView source →Cost-Effectiveness Analyses of Vaccination Programmes: A Review of Modelling Approaches — Kim & Goldie, Vol. 26, No. 3 ed., 2008 (PharmacoEconomics)
A systematic review of the modelling approaches used in cost-effectiveness analyses of vaccination programmes, presenting a framework for categorising models (static/dynamic, deterministic/stochastic, aggregate/individual) across 276 vaccine CEAs.
Journal ArticleView source →A Systematic Review of the Cost and Cost-Effectiveness Studies of Immune Checkpoint Inhibitors — Verma, Sprave, Haque, et al., Vol. 6 ed., 2018 (Journal for ImmunoTherapy of Cancer)
A PRISMA-guided systematic review of cost-effectiveness studies of immune checkpoint inhibitors across head/neck, lung, genitourinary and melanoma cancers, a key reference for the economics of high-cost immuno-oncology therapies.
Journal ArticleView source →
Media
1
Infectious Disease Modelling Specialization — Imperial College London, 3-course specialization ed., 2023 (Coursera)
An Imperial College London specialization introducing mathematical modelling of infectious disease in R — compartmental and dynamic transmission models — foundational for the economic evaluation of vaccines and control programmes.
Online CourseView source →
Frequently Asked Questions (6)
What is a dynamic transmission model?
An epidemiological model representing how infection risk for a susceptible individual depends on current population prevalence, capturing feedback such as herd immunity.
Source: Kermack & McKendrick 1927
Why do vaccination evaluations often require a dynamic transmission model?
Vaccinating part of a population changes the risk faced by everyone else, because fewer infectious people means fewer chances to catch the disease, so a vaccine protects the unvaccinated as well as those who receive it. A model that holds infection risk fixed cannot represent this indirect protection and will understate a vaccine's benefit. A dynamic transmission model lets risk depend on how many are currently infected, so it captures herd effects. This is why such models are recommended for vaccine evaluation. Pitman and colleagues (2012) explain the requirement.
Source: Pitman et al. 2012
How does a dynamic transmission model represent infection risk?
A dynamic transmission model represents infection risk through the force of infection, the rate at which susceptible individuals become infected, which depends on the current number of infectious people and the rate of effective contact. As prevalence rises, the force of infection rises, and as prevalence falls, it falls, so the risk is not fixed but changes with the state of the epidemic. This dependence of individual risk on population prevalence is the defining feature that makes the model dynamic.
Source: Kermack & McKendrick 1927
How does a dynamic transmission model differ from a static model?
A dynamic transmission model lets the risk of infection depend on current prevalence, so that reducing infection in some people lowers risk for others, whereas a static model treats each person's risk as fixed and independent. This difference matters for interventions like vaccination: a dynamic model captures herd immunity, the indirect protection of the unvaccinated as transmission falls, which a static model cannot. Dynamic models are therefore needed to evaluate interventions whose benefits work through reduced transmission.
Source: Kermack & McKendrick 1927
Why is herd immunity captured by dynamic transmission models?
Herd immunity is captured by dynamic transmission models because they make infection risk depend on prevalence: as vaccination reduces the number of infectious people, the force of infection falls for everyone, protecting even the unvaccinated. This indirect effect, where individuals benefit from the immunity of others, arises from the feedback between prevalence and risk that dynamic models represent. A static model, treating risk as fixed, would miss herd immunity and so understate the population benefit of vaccination and other transmission-reducing interventions.
Source: Kermack & McKendrick 1927
When should a dynamic transmission model be used?
A dynamic transmission model should be used when evaluating interventions for infectious diseases whose effects work through changing transmission, such as vaccination, treatment that reduces infectiousness, or control measures, where herd immunity and other indirect effects are important. In these cases a static model, ignoring the dependence of risk on prevalence, would misestimate the benefit. Where an intervention does not affect transmission, or indirect effects are negligible, a simpler static model may suffice, so the choice depends on whether transmission dynamics matter.
Source: Kermack & McKendrick 1927
Trust Record
Verified by Dr Darrin Baines
British health economist
Professional identity: darrinbaines.org
Verification date: 29 Sep 2025
Content version: 1.0.0
Canonical Identity
- Term code
- HE-EM-DM-027
Stable URI · Machine-readable · Resolvable · CC BY 4.0